Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/01/24
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 09/02/23
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 11/14/24
End: 10/31/25
Due: 10/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety, Tolerability, and Effectiveness of Duodenal Mucosal RF Vapor Ablation for Insulin Elimination in Type-2 Diabetes | NCT06655740 | Aqua Medical, Inc. | user2@example.com | None | 2024-10-01 | 2025-07-31 | 2026-07-31 | - | - | 2025-07-14 |
| Study of Duodenal Mucosal RF Vapor Ablation in Subjects With Type-2 Diabetes Mellitus | NCT05887635 | Aqua Medical, Inc. | user2@example.com | None | 2023-09-02 | 2026-06-30 | 2027-06-30 | - | - | 2025-07-14 |
| RF Vapor Ablation Retreatment of Duodenal Mucosa in Non-responders With Type-2 Diabetes Mellitus | NCT06724822 | Aqua Medical, Inc. | user2@example.com | None | 2024-11-14 | 2025-10-31 | 2026-10-31 | - | - | 2025-07-14 |